BioArctic AB (STO:BIOA-B) a Swedish research-based biopharma company focused on innovative treatments for neurodegenerative diseases, announced on Thursday that it will publish its second quarter report for April-June 2025 on Thursday, August 28, 2025, at 08:00 a.m. CET.

Investors, analysts, and media are invited to an audiocast with teleconference (in English) on August 28, at 09:30 CET, where BioArctic CEO Gunilla Osswald, CFO Anders Martin-Lof, and colleagues will present and comment on the second quarter report, followed by a Q&A session.

Those wishing to participate via webcast can do so at https://bioarctic.events.inderes.com/q2-report-2025/register. Written questions can be asked via the webcast.

To participate via teleconference, register at https://events.inderes.com/bioarctic/q2-report-2025/dial-in to receive a phone number and conference ID. Those participating via teleconference can ask questions verbally during the event.

The webcast will also be available on demand on BioArctic's corporate website https://www.bioarctic.com/en/investors/financial-reports-and-presentations/ after the presentation.